You are leaving Lundbeck.com/US

You have chosen to visit another Lundbeck website or a third-party website, which is provided as a service to you. Lundbeck does not control content on third-party websites and cannot make representations concerning the accuracy of information on every website you visit. Lundbeck is not responsible for the privacy policy of any third-party website. We encourage you to read the privacy policy of every website you visit.

Click here to proceed

Cancel

Lundbeck in the US

When it comes to advancing therapies for brain diseases, we stand apart

For more than 70 years, Lundbeck has been at the forefront of brain science. We are committed to providing transformative therapies for brain diseases, and we are dedicated to advancing brain health and transforming lives.

In the United States, our nearly 1,000 employees stand shoulder-to-shoulder with patients, families and caregivers impacted by brain diseases. The unmet need in brain disease is vast, but we strive to see the person behind the disease, and we have deep connections with the communities we serve.

Lundbeck US Fast Facts

Our Operations

  • Largest affiliate of H. Lundbeck A/S
  • Global headquarters in Copenhagen, Denmark
  • US headquarters located in Deerfield, Ill. (suburban Chicago)
  • Scientific operations at the Lundbeck La Jolla Research Center in southern California and Lundbeck Seattle BioPharmaceuticals, Inc., in Bothell, Washington
  • Marketed pharmaceuticals in depression, bipolar disorder, schizophrenia, migraine prevention and agitation associate with dementia due to Alzheimer's disease

Our People

  • Nearly 1,000 US employees
  • Deeply committed to our patient communities, with close ties to patient advocacy organizations in our focus areas
  • Ranked as leader in corporate reputation among leading pharmaceutical companies by patient groups
  • Engaged in research collaborations with industry partners, academic institutions and government agencies

What sets us apart:

More from Lundbeck